A study of the
efficacy of intermittent intravenous bisphosphonate in the treatment of
conservatively managed primary hyperparathyroid patients with osteoporosis
has been published at the 8th Conference of the National Osteoporosis Society2001.
The study analysed the treatment outcomes in this subset of patients, from
an existing database covering a period of 6 years.
A study of postmenopausal Primary
Hyperparathyroid patients to ascertain the prevalence and pattern of
osteoporotic involvement;
Medical Research Society Meeting, London, 2002 for pdf version click
here
Increased Glucagon-like peptide-1 (GLP-1)
Secretion in response to
Acute Intralipid-Induced Hypertriglyceridaemia. Focus meeting: the
Association of Clinical Biochemists; Brighton 2006. Poster W80View pdf here.